Biotech and Pharmaceutical
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  US Device


Market Summary

Company Profiles


Research Store

Biotech Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

Bristol-Myers Squibb Company 

38 Jackson Road

Devens  Massachusetts  01434  U.S.A.
Phone: n/a Fax: n/a


Bristol-Myers Squibb is a global biopharmaceutical company dedicated to helping patients prevail against serious disease.

We have delivered nine new products to patients in the last seven years for the treatment of psychiatric disorders, cancer, HIV, chronic hepatitis B and rheumatoid arthritis. We anticipate up to 6 additional regulatory approvals or submissions through 2012. In addition, scores of investigational medicines are advancing through our pharmaceutical development pipeline for such additional diseases as diabetes and cardiovascular disease, solid organ transplant rejection, Alzheimer's and obesity.

Bristol-Myers Squibb is recognized as having one of the most productive pipelines in the industry. Two of our marketed productive pipelines in the industry. Two of our marketed medicines and a number of investigational products are biologics. In the fight against serious disease, biologics - or protein-derived therapies - are playing an increasingly prominent role.

In our quest to help patients prevail, we are redefining our company and transforming ourselves for the future. By uniquely combining the strengths of a traditional pharmaceutical company with the attributes of a successful biotech company, we are becoming a new kind of enterprise, a next generation BioPharma. We are focused - agile and flexible, and infused with the entrepreneurial culture of an innovative biotech. Yet, at the same time, we are large enough to marshal the resources necessary to invest in our pipeline and bring new medicines to patients in need.

As a BioPharma leader, we are complementing and enhancing our internal capabilities with innovative alliances, partnerships and acquisitions. We call this our String of Pearls strategy.

Over the years, Bristol-Myers Squibb and its employees have received numerous distinguished awards and recognitions, including the National Medal of Technology and the Lasker Award for Medical Research. Recently, Bristol-Myers Squibb was included among Barron's 2009 Most Respected Companies Survey. Also, we've been hailed year after year as one of the best companies for working mothers and executive women, and as an acknowledged industry leader in environment, health, and safety management.

 Key Statistics

Ownership: Public

Web Site: Bristol-Myers Squibb Company
Symbol: BMY

 Company News
Bristol-Myers Squibb Company (BMY) And Samsung Biologics Expand Manufacturing Agreement 4/23/2014 6:32:42 AM    More...
Bristol-Myers Squibb Company (BMY)'s Hepatitis C Drug Cures Up To 90 Percent In Phase 3 Study 4/10/2014 6:50:16 AM    More...
Bristol-Myers Squibb Company (BMY) To Announce Results For First Quarter 2014 On April 29 4/1/2014 7:48:13 AM    More...
Bristol-Myers Squibb Company (BMY) Executive Maclean Becomes Precision Health Economics' Chief Operating Officer 3/31/2014 8:33:42 AM    More...
Bristol-Myers Squibb Company (BMY)'s Eliquis® Works As Well As Pfizer Inc. (PFE)'s In Head-To-Head Subanalysis Study 3/27/2014 6:58:32 AM    More...
Big Pharmas Such As Bristol-Myers Squibb Company (BMY), Roche Holding AG (RHHBF.PK), And Merck & Co., Inc. (MRK) Race To Launch Breakthrough Melanoma Drugs 3/25/2014 7:33:05 AM    More...
Bristol-Myers Squibb Company (BMY) To Shed 160 Jobs Due To Facility Shut Down 3/7/2014 7:18:31 AM    More...
Bristol-Myers Squibb Company (BMY) Plans Big Lung Cancer Study, Pairing Immunotherapies 3/5/2014 6:26:21 AM    More...
Bristol-Myers Squibb Company (BMY) Announces Dividend 3/4/2014 7:49:27 AM    More...
Bristol-Myers Squibb Company (BMY)'s Experimental Drug Helps Body Fight Advanced Melanoma 3/4/2014 7:40:20 AM    More...